---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-024305"
form_type: "8-K"
ticker: "KRRO"
cik: "0001703647"
company_name: "Korro Bio, Inc."
filed_at: "2025-02-11T23:59:59+00:00"
generated_at: "2026-05-26T23:26:55.781491+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Korro Bio CFO Vineet Agarwal takes temporary medical leave; CEO Ram Aiyar named interim principal financial officer

## Summary
- Effective Feb 11, 2025, CFO Vineet Agarwal on temporary medical leave from Korro Bio.
- CEO Ram Aiyar appointed interim principal financial officer; no additional compensation.
- Oliver Dolan, SVP Finance, appointed interim principal accounting officer.
- Dolan has served as SVP Finance since Jan 2024; previously at Unity Biotechnology, Haven Healthcare, Compass Therapeutics.

## SEC filing metadata
- accession: 0001193125-25-024305
- form_type: 8-K
- ticker: KRRO
- cik: 0001703647
- company_name: Korro Bio, Inc.
- filed_at: 2025-02-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703647/000119312525024305/0001193125-25-024305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703647/000119312525024305/d892089d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-024305
- JSON: https://secwatch.observer/filing/0001193125-25-024305.json
- Plain text: https://secwatch.observer/filing/0001193125-25-024305.txt

## Key facts
- Executive change
  Vineet Agarwal changed role as Chief Financial Officer at Korro Bio, Inc..
  - Action: taking a temporary medical leave of absence
  - Role: Chief Financial Officer
  source text: Effective February 11, 2025, Vineet Agarwal, Chief Financial Officer (principal financial officer and principal accounting officer) of Korro Bio, Inc., or Korro, is taking a temporary medical leave of absence.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703647/000119312525024305/0001193125-25-024305-index.htm
- Executive change
  Oliver Dolan was appointed as Interim Principal Accounting Officer at Korro Bio, Inc..
  - Action: appointed
  - Role: Interim Principal Accounting Officer
  source text: and Mr. Oliver Dolan, Senior Vice President, Finance, to serve as Korro’s interim principal accounting officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703647/000119312525024305/0001193125-25-024305-index.htm
- Executive change
  Ram Aiyar was appointed as Interim Principal Financial Officer at Korro Bio, Inc..
  - Action: appointed
  - Role: Interim Principal Financial Officer
  source text: Korro’s Board of Directors appointed Dr. Ram Aiyar, President and Chief Executive Officer (principal executive officer), to serve as Korro’s interim principal financial officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703647/000119312525024305/0001193125-25-024305-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.